Matsuda A, Makino N, Tozawa T, Shirahata N, Honda T, Ikeda Y, et al
Current Legal Status (As of 2026) As of early 2026, the legal status of compounded GLP-1 medications can be summarized as follows: Compounded semaglutide: The regulatory picture for compounded semaglutide is complex
Just as important, the care is delivered nationally through an app and chat, with clinicians you connect with remotely rather than a doctor you see in person
Key Things We Consider Initial metabolic levels and body composition Previous use of appetite-related medications Sensitivity to digestion changes when starting treatment Weekly appetite shifts Goals for the long run and when to expect results Starting with smaller doses helps the body adapt over time
They're not FDA approved and regulated the same way," Peavie said